M D 3 3 (Doxycycline hyclate delayed-release 150 mg)

Pill imprint M D 3 3 has been identified as Doxycycline hyclate delayed-release 150 mg.

Doxycycline is used in the treatment of bacterial infection; acne; lyme disease; urinary tract infection; chlamydia infection (and more), and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxycycline hyclate delayed-release

Imprint:

M D 3 3

Strength:

150 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Miscellaneous antimalarials
Tetracyclines

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-3030

Inactive Ingredients:

lactose anhydrous
silicon dioxide
crospovidone
hypromellose phthalate (24% phthalate, 55 cst)
lactose monohydrate
povidone
corn starch
sodium chloride
sodium lauryl sulfate
stearic acid
magnesium silicate
triethyl citrate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.